First Trust Advisors’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8M Sell
299,494
-47,992
-14% -$1.61M 0.01% 1182
2026
Q1
$12.5M Buy
347,486
+92,368
+36% +$2.39M 0.01% 1017
2025
Q4
$5.07M Buy
255,118
+98,754
+63% +$1.9M ﹤0.01% 1397
2025
Q3
$2.85M Buy
+156,364
New +$2.57M ﹤0.01% 1672
2025
Q2
Sell
-222,658
Closed -$2.82M 2612
2025
Q1
$2.82M Buy
222,658
+19,055
+9% +$299K ﹤0.01% 1622
2024
Q4
$4.48M Buy
+203,603
New +$4.28M ﹤0.01% 1422

Other funds holding CLMT

First Trust Advisors's CLMT Position: Q2 2026 in Review

First Trust Advisors reduced its Calumet Specialty Products (CLMT) stake by 14% in Q2 2026, selling an estimated $1.61M and leaving 299,494 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #1182.

First Trust Advisors first reported a position in CLMT in Q4 2024 and has held it in 6 quarters since. The position peaked at $12.5M in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • First Trust Advisors held 299,494 shares of Calumet Specialty Products worth $10.8M as of Q2 2026.
  • First Trust Advisors sold 47,992 Calumet Specialty Products shares in Q2 2026, an estimated $1.61M.
  • Calumet Specialty Products made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #1182 holding.
  • First Trust Advisors first reported a position in Calumet Specialty Products in Q4 2024 and has held it in 6 quarters since.
  • First Trust Advisors's Calumet Specialty Products position peaked at $12.5M in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.